Clinical Trial Update: Medical Cannabis for Nausea in Patients Receiving Moderately or Highly Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating medical cannabis for chemotherapy-induced nausea and vomiting, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Medical Cannabis (cannabis)

Snippet

Sponsor: University of Rochester | Conditions: Nausea and Vomiting Chemotherapy-Induced | Phase 2 | Status: NOT_YET_RECRUITING